Insider Transactions in Q3 2025 at Medtronic PLC (MDT)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2025
|
Harry Skip Kiil EVP & President Cardiovascular |
SELL
Open market or private sale
|
Direct |
8,605
-9.78%
|
$783,055
$91.58 P/Share
|
|
Aug 25
2025
|
William R Jellison Director |
BUY
Open market or private purchase
|
Direct |
2,500
+33.33%
|
$230,000
$92.37 P/Share
|
|
Aug 22
2025
|
William R Jellison Director |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$230,000
$92.73 P/Share
|
|
Aug 20
2025
|
Michael Marinaro EVP, Pres MedSurg and Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
1,052
-1.99%
|
$97,836
$93.22 P/Share
|
|
Aug 01
2025
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
11,594
-9.09%
|
$1,031,866
$89.34 P/Share
|
|
Aug 01
2025
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
15,249
+18.65%
|
-
|
|
Aug 01
2025
|
Matthew R. Walter SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,910
-1.95%
|
$169,990
$89.34 P/Share
|
|
Aug 01
2025
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,142
+4.54%
|
$122,538
$39.0 P/Share
|
|
Aug 01
2025
|
Denise L. Blomquist Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
515
-1.02%
|
$45,835
$89.34 P/Share
|
|
Aug 01
2025
|
Denise L. Blomquist Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
518
+1.34%
|
$13,468
$26.0 P/Share
|
|
Aug 01
2025
|
Harry Skip Kiil EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
7,555
-7.57%
|
$672,395
$89.34 P/Share
|
|
Aug 01
2025
|
Harry Skip Kiil EVP & President Cardiovascular |
BUY
Exercise of conversion of derivative security
|
Direct |
10,457
+16.8%
|
-
|
|
Aug 01
2025
|
Michael Marinaro EVP, Pres MedSurg and Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
7,763
-4.6%
|
$690,907
$89.34 P/Share
|
|
Aug 01
2025
|
Michael Marinaro EVP, Pres MedSurg and Americas |
BUY
Exercise of conversion of derivative security
|
Direct |
9,661
+7.74%
|
$376,779
$39.0 P/Share
|
|
Aug 01
2025
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
77,175
-9.21%
|
$6,868,575
$89.34 P/Share
|
|
Aug 01
2025
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
98,324
+14.69%
|
$3,834,636
$39.0 P/Share
|
|
Aug 01
2025
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
7,114
-4.37%
|
$633,146
$89.34 P/Share
|
|
Aug 01
2025
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Exercise of conversion of derivative security
|
Direct |
11,328
+12.0%
|
-
|
|
Jul 31
2025
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,630
-2.22%
|
$146,700
$90.24 P/Share
|
|
Jul 28
2025
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,350
+12.44%
|
-
|
|
Jul 28
2025
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,513
+14.24%
|
-
|
|
Jul 28
2025
|
Thierry Pieton EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,699
+17.88%
|
-
|
|
Jul 28
2025
|
Michelle Quinn EVP, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
21,747
+46.43%
|
-
|
|
Jul 28
2025
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
9,786
+11.77%
|
-
|
|
Jul 28
2025
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
9,786
+16.02%
|
-
|
|
Jul 28
2025
|
Michael Marinaro EVP, Pres MedSurg and Americas |
BUY
Grant, award, or other acquisition
|
Direct |
9,786
+16.07%
|
-
|
|
Jul 28
2025
|
Denise L. Blomquist Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,202
+15.05%
|
-
|
|
Jul 28
2025
|
Harry Skip Kiil EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
7,612
+15.56%
|
-
|